Unlike its incompletely understood role in chemotherapy, KCa3.1 has consistently been demonstrated to exert pro-survival functions in ionizing radiation-treated T cell leukemia [27], lung adenocarcinoma [19], and glioblastoma [21,28]. Here, KCNN4 is linked to T-cell leukemia.